Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 5.02 · 8-K

Alpine Auto Brokers Inc

ALTBOTCEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, Compensatory Arrangement of Certain Officers On September 18, 2026, the Board of Directors of Alpine Auto Brokers, Inc. (OTC: ALTB) (the “Company”) appointed Ms. Fang Gao as a member of the Company’s Board of Directors, effective immediately. Ms.…

Filed Sep 18, 2026Accepted Sep 18, 2026, 9:30 AM EDTCIK 1642365Accession 0001829126-26-010209
Share

Company context

Current securities

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 5, 2025
  2. Other EventsAug 5, 2025
  3. RW filingOct 27, 2023
  4. 8-K filingOct 16, 2023
  5. S-1/A filingSep 19, 2023

Disclosure sections

Items 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, Compensatory Arrangement of Certain Officers On September 18, 2026, the Board of Directors of Alpine Auto Brokers, Inc. (OTC: ALTB) (the “Company”) appointed Ms. Fang Gao as a member of the Company’s Board of Directors, effective immediately. Ms. Gao has extensive experience in corporate management, business operations, marketing, and the biotechnology and health industries. From 2016 to 2021, she held several senior management positions with Tangshan Future Biotechnology Co., Ltd., including Assistant to the Chairman, Vice President of Operations, and Executive President. Since December 2021, she has served as Chairwoman and General Manager of Hangzhou Gongshengyuan Biotechnology Co., Ltd. Ms. Gao holds an undergraduate degree in Traditional Chinese Medicine from Heilongjiang University of Chinese Medicine and a graduate degree in Industrial Economics from Wuhan University of Technology. The Company believes that Ms. Gao’s management experience and industry background will contribute positively to the Board’s oversight and strategic development.